Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Diabetes: Daily Aspirin or Other Antiplatelet for Diabetes Patients with Ischemic Vascular Disease (IVD) Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 13 Clinics in the ProHealth Care health system


The results below represent the care of 499 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ProHealth Medical Group, Inc. (Oconomowoc - Corporate Center Dr.)
N=114
96.49 %
View Historical Data
ProHealth Medical Group, Inc. Brookfield

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Delafield

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Hartland

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Mukwonago

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Muskego

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. New Berlin

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Pewaukee
N=129
98.45 %
View Historical Data
ProHealth Medical Group, Inc. Sussex

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Watertown

The number of patients or providers is too small for
purposes of reliably reporting performance
ProHealth Medical Group, Inc. Waukesha Big Bend
N=152
98.03 %
View Historical Data
ProHealth Medical Group, Inc. Waukesha Moreland
N=104
99.04 %
View Historical Data
ProHealth Medical Group, Inc.Oconomowoc (OB/Gyn Clinic at Oconomowoc Memorial Hospital)

The number of patients or providers is too small for
purposes of reliably reporting performance

Based on trials involving other secondary prevention therapies, the American College of Cardiology (ACC) and the American Heart Assocation (AHA) recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions. The American Diabetes Association (ADA) supports this recommendation as a secondary prevention strategy for type 1 or type 2 diabetes with a history of cardiovascular disease.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.